Switzerland vs World: Access to anti-retroviral drugs, male
Switzerland
90.0%
in 2023
World
73.0%
in 2024
Switzerland rank
13th
World rank
15th
Access to anti-retroviral drugs, male over time
- Switzerland
- World
How they compare
Switzerland currently reports 90.0% against 73.0% in World, a difference of 17.0%.
That makes Switzerland's figure about 1.2 times World's.
Across all 24 years both countries report, Switzerland has been ahead every year.
Switzerland ranks 13th and World ranks 15th of 141 countries.
Switzerland has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Switzerland | World | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 50.0% | 7.1% | 42.9% | Switzerland |
| 2010s | 79.2% | 40.6% | 38.6% | Switzerland |
| 2020s | 90.2% | 66.2% | 24.0% | Switzerland |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, male, Switzerland or World?
- Switzerland, at 90.0% against 73.0% in World as of 2023.
- What is the difference in access to anti-retroviral drugs, male between Switzerland and World?
- 17.0%, with Switzerland ahead.
- How many years of comparable data are there for Switzerland and World?
- 24 years are reported by both, from 2000 to 2023.
- How do Switzerland and World rank globally for access to anti-retroviral drugs, male?
- Switzerland ranks 13th and World ranks 15th of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, male (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult males living with HIV who are receiving antiretroviral therapy.